FDA Approved: ZILRETTA — Supplemental Application (Pacira Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ZILRETTA (triamcinolone acetonide extended-release injectable suspension) submitted by Pacira Pharmaceuticals, I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• ZILRETTA (Triamcinolone acetonide extended-release injectable suspension)

Snippet

SUPPL AP for ZILRETTA (TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION)